TriSalus Life Sciences (TLSI) Competitors $5.16 -0.06 (-1.15%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$5.16 +0.00 (+0.10%) As of 09/2/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLSI vs. KMTS, INMD, IRMD, EMBC, TNDM, BBNX, AXGN, SIBN, BVS, and KIDSShould you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Kestra Medical Technologies (KMTS), InMode (INMD), iRadimed (IRMD), Embecta (EMBC), Tandem Diabetes Care (TNDM), Beta Bionics (BBNX), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. TriSalus Life Sciences vs. Its Competitors Kestra Medical Technologies InMode iRadimed Embecta Tandem Diabetes Care Beta Bionics AxoGen SiBone Bioventus OrthoPediatrics Kestra Medical Technologies (NASDAQ:KMTS) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk. Which has stronger earnings and valuation, KMTS or TLSI? TriSalus Life Sciences has lower revenue, but higher earnings than Kestra Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKestra Medical Technologies$59.81M13.84-$113.81MN/AN/ATriSalus Life Sciences$29.43M8.74-$30.05M-$1.18-4.37 Do analysts rate KMTS or TLSI? Kestra Medical Technologies currently has a consensus price target of $27.33, suggesting a potential upside of 69.56%. TriSalus Life Sciences has a consensus price target of $10.75, suggesting a potential upside of 108.33%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe TriSalus Life Sciences is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Do institutionals and insiders have more ownership in KMTS or TLSI? 2.6% of TriSalus Life Sciences shares are owned by institutional investors. 3.6% of Kestra Medical Technologies shares are owned by insiders. Comparatively, 27.5% of TriSalus Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer KMTS or TLSI? In the previous week, Kestra Medical Technologies had 8 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 8 mentions for Kestra Medical Technologies and 0 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.88 beat Kestra Medical Technologies' score of 0.92 indicating that TriSalus Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Kestra Medical Technologies Positive TriSalus Life Sciences Very Positive Is KMTS or TLSI more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -86.61%. Company Net Margins Return on Equity Return on Assets Kestra Medical TechnologiesN/A N/A N/A TriSalus Life Sciences -86.61%N/A -116.50% SummaryTriSalus Life Sciences beats Kestra Medical Technologies on 8 of the 13 factors compared between the two stocks. Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSI vs. The Competition Export to ExcelMetricTriSalus Life SciencesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$260.31M$10.88B$5.77B$9.76BDividend YieldN/A1.84%6.66%4.49%P/E Ratio-4.3721.6183.0526.39Price / Sales8.7431.35527.23108.99Price / CashN/A25.1325.7028.92Price / Book-13.233.4511.006.58Net Income-$30.05M$211.94M$3.28B$265.84M7 Day Performance1.18%-0.78%-0.19%-0.26%1 Month Performance23.44%13.38%8.33%5.82%1 Year Performance3.61%-7.31%53.31%22.47% TriSalus Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSITriSalus Life Sciences3.3529 of 5 stars$5.16-1.1%$10.75+108.3%-1.7%$260.31M$29.43M-4.37106Positive NewsKMTSKestra Medical Technologies1.3644 of 5 stars$18.53+4.6%$27.33+47.5%N/A$951.52M$59.81M0.00300News CoveragePositive NewsLockup ExpirationINMDInMode3.8062 of 5 stars$14.88+2.1%$18.04+21.2%-13.8%$940.57M$394.82M6.02480Positive NewsIRMDiRadimed4.8327 of 5 stars$72.69+1.7%$72.00-0.9%+52.5%$924.62M$73.24M44.87110Positive NewsEMBCEmbecta4.6328 of 5 stars$14.21-0.4%$19.00+33.7%-10.5%$831.14M$1.12B9.942,100Positive NewsTNDMTandem Diabetes Care4.6646 of 5 stars$12.24+1.1%$22.47+83.6%-70.6%$827.06M$940.20M-3.962,650Positive NewsShort Interest ↓BBNXBeta Bionics1.0265 of 5 stars$18.33+5.0%$22.56+23.1%N/A$796.81M$78.02M0.00294News CoverageAXGNAxoGen3.315 of 5 stars$16.21+9.6%$26.00+60.4%+19.5%$745.82M$187.34M-162.08450Short Interest ↓Gap DownSIBNSiBone4.1295 of 5 stars$16.42+2.3%$23.67+44.1%-1.0%$708.36M$167.18M-29.32350BVSBioventusN/A$7.27-2.3%N/AN/A$601.08M$573.28M15.281,200High Trading VolumeKIDSOrthoPediatrics4.4097 of 5 stars$22.12+9.0%$34.14+54.4%-34.9%$554.55M$204.73M-12.36200News Coverage Related Companies and Tools Related Companies Kestra Medical Technologies Competitors InMode Competitors iRadimed Competitors Embecta Competitors Tandem Diabetes Care Competitors Beta Bionics Competitors AxoGen Competitors SiBone Competitors Bioventus Competitors OrthoPediatrics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLSI) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLSI Stock Alerts